LAGOS, March 25 (Reuters) - The Nigerian unit of British drugmaker GlaxoSmithKline on Tuesday reported2013 pretax profit up 3.4 percent to 4.31 billion naira ($26million), from 4.17 billion naira the previous year.
Turnover grew 15.3 percent to 29.18 billion naira during theperiod, compared with 25.31 billion naira a year earlier, thecompany said in a filing with the Nigerian Stock Exchange. ($1 = 165.19 Naira) (Reporting by Oludare Mayowa; Editing by David Goodman)